Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2333 studies found for:    pancreatic cancer
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: laboratory biomarker analysis
2 Completed
Has Results
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Ipilimumab;   Biological: Pancreatic Cancer Vaccine
3 Completed Studying Biomarkers in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis
4 Completed Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
5 Recruiting Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: GAX - Gemcitabine, Abraxane and Xeloda
6 Terminated Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
7 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
8 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
9 Withdrawn HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: interventional therapy
10 Completed A Phase III Study of Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
11 Unknown  Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
12 Recruiting Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab Trial for Surgically Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Cyclophosphamide;   Biological: GVAX pancreatic cancer;   Drug: Nivolumab
13 Enrolling by invitation Clinical Trial of Pancreatic Cancer in Stockholm.
Condition: Pancreatic Cancer
Intervention: Procedure: Pancreatic Surgery
14 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
Intervention:
15 Active, not recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Biological: GVAX pancreatic cancer vaccine;   Drug: cyclophosphamide
16 Enrolling by invitation Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Procedure: Electroporation/ Nano knife treatment;   Device: NanoKnife
17 Active, not recruiting Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
Condition: Pancreatic Cancer
Intervention: Behavioral: Questionnaire
18 Recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
19 Completed
Has Results
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: RAD001
20 Recruiting Olaparib for BRCAness Phenotype in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Olaparib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.